{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:45Z","timestamp":1707525165803},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,12]]},"DOI":"10.7759\/cureus.40283","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T09:13:47Z","timestamp":1686561227000},"source":"Crossref","is-referenced-by-count":0,"title":["Limited Value of Bladder Wash Cytology During Follow-Up of Patients With Non-muscle Invasive Bladder Cancer"],"prefix":"10.7759","author":[{"given":"Uwe","family":"Bieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedikt","family":"Kranzb\u00fchler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian S","family":"Wettstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian D","family":"Fankhauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basil P","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burkhardt","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter K","family":"Bode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9dric","family":"Poyet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Lenggenhager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Hermanns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"GLOBOCAN 2012. estimated cancer incidence, mortality and prevalence worldwide in 2012 v1.0. (2012). Accessed: July 5, 2020: https:\/\/publications.iarc.fr\/Databases\/Iarc-Cancerbases\/GLOBOCAN-2012-Estimated-Cancer-Incidence-Mortality-And-Preval...."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger M","year":"2013","unstructured":"Burger M, Catto JW, Dalbagni G, et al.. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013, 63:234-41. 10.1016\/j.eururo.2012.07.033","journal-title":"Eur Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ) - 2019 update","volume":"76","author":"Babjuk M","year":"2019","unstructured":"Babjuk M, Burger M, Comp\u00e9rat EM, et al.. European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ) - 2019 update. Eur Urol. 2019, 76:639-57. 10.1016\/j.eururo.2019.08.016","journal-title":"Eur Urol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.08.150","article-title":"Cystoscopy revisited as the gold standard for detecting bladder cancer recurrence: diagnostic review bias in the randomized, prospective CEFUB trial","volume":"183","author":"van der Aa MN","year":"2010","unstructured":"van der Aa MN, Steyerberg EW, Bangma C, van Rhijn BW, Zwarthoff EC, van der Kwast TH. Cystoscopy revisited as the gold standard for detecting bladder cancer recurrence: diagnostic review bias in the randomized, prospective CEFUB trial. J Urol. 2010, 183:76-80. 10.1016\/j.juro.2009.08.150","journal-title":"J Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2016.05.028","article-title":"Follow-up in non-muscle-invasive bladder cancer\u2014International Bladder Cancer Network recommendations","volume":"34","author":"Kassouf W","year":"2016","unstructured":"Kassouf W, Traboulsi SL, Schmitz-Dr\u00e4ger B, et al.. Follow-up in non-muscle-invasive bladder cancer\u2014International Bladder Cancer Network recommendations. Urol Oncol. 2016, 34:460-8. 10.1016\/j.urolonc.2016.05.028","journal-title":"Urol Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19871001)60:7<1423::aid-cncr2820600702>3.0.co;2-6","article-title":"The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma","volume":"60","author":"Badalament RA","year":"1987","unstructured":"Badalament RA, Hermansen DK, Kimmel M, et al.. The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma. Cancer. 1987, 60:1423-7. 10.1002\/1097-0142(19871001)60:7&lt;1423::aid-cncr2820600702&gt;3.0.co;2-6","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2016.4556","article-title":"ImmunoCyt test compared to cytology in the diagnosis of bladder cancer: a meta-analysis","volume":"12","author":"He H","year":"2016","unstructured":"He H, Han C, Hao L, Zang G. ImmunoCyt test compared to cytology in the diagnosis of bladder cancer: a meta-analysis. Oncol Lett. 2016, 12:83-8. 10.3892\/ol.2016.4556","journal-title":"Oncol Lett"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0090-4295(02)02136-2","article-title":"Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses","volume":"61","author":"Lotan Y","year":"2003","unstructured":"Lotan Y, Roehrborn CG. Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses. Urology. 2003, 61:109-18. 10.1016\/s0090-4295(02)02136-2","journal-title":"Urology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2005.03.014","article-title":"Urine markers for bladder cancer surveillance: a systematic review","volume":"47","author":"van Rhijn BW","year":"2005","unstructured":"van Rhijn BW, van der Poel HG, van der Kwast TH. Urine markers for bladder cancer surveillance: a systematic review. Eur Urol. 2005, 47:736-48. 10.1016\/j.eururo.2005.03.014","journal-title":"Eur Urol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)65387-6","article-title":"Four bladder tumor markers have a disappointingly low sensitivity for small size and low grade recurrence","volume":"167","author":"Boman H","year":"2002","unstructured":"Boman H, Hedelin H, Holm\u00e4ng S. Four bladder tumor markers have a disappointingly low sensitivity for small size and low grade recurrence. J Urol. 2002, 167:80-3. 10.1016\/S0022-5347(05)65387-6","journal-title":"J Urol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)64827-4","article-title":"Diagnostic accuracy of urinary cytology, and deoxyribonucleic acid flow cytometry and cytology on bladder washings during followup for bladder tumors","volume":"157","author":"Gr\u00e9goire M","year":"1997","unstructured":"Gr\u00e9goire M, Fradet Y, Meyer F, et al.. Diagnostic accuracy of urinary cytology, and deoxyribonucleic acid flow cytometry and cytology on bladder washings during followup for bladder tumors. J Urol. 1997, 157:1660-4. 10.1016\/S0022-5347(01)64827-4","journal-title":"J Urol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(92)90288-8","article-title":"Value of urine cytology versus bladder washing in bladder cancer","volume":"39","author":"Matzkin H","year":"1992","unstructured":"Matzkin H, Moinuddin SM, Soloway MS. Value of urine cytology versus bladder washing in bladder cancer. Urology. 1992, 39:201-3. 10.1016\/0090-4295(92)90288-8","journal-title":"Urology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000446270","article-title":"The Paris System for Reporting Urinary Cytology: the quest to develop a standardized terminology","volume":"60","author":"Barkan GA","year":"2016","unstructured":"Barkan GA, Wojcik EM, Nayar R, Savic-Prince S, Quek ML, Kurtycz DF, Rosenthal DL. The Paris System for Reporting Urinary Cytology: the quest to develop a standardized terminology. Acta Cytol. 2016, 60:185-97. 10.1159\/000446270","journal-title":"Acta Cytol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3109\/00365599.2010.533694","article-title":"Comparison of the sensitivity and specificity of urine cytology, urinary nuclear matrix protein-22 and multitarget fluorescence in situ hybridization assay in the detection of bladder cancer","volume":"45","author":"Kehinde EO","year":"2011","unstructured":"Kehinde EO, Al-Mulla F, Kapila K, Anim JT. Comparison of the sensitivity and specificity of urine cytology, urinary nuclear matrix protein-22 and multitarget fluorescence in situ hybridization assay in the detection of bladder cancer. Scand J Urol Nephrol. 2011, 45:113-21. 10.3109\/00365599.2010.533694","journal-title":"Scand J Urol Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3233\/BLC-150034","article-title":"Comparison of guidelines on non-muscle invasive bladder cancer (EAU, CUA, AUA, NCCN, NICE)","volume":"2","author":"Power NE","year":"2016","unstructured":"Power NE, Izawa J. Comparison of guidelines on non-muscle invasive bladder cancer (EAU, CUA, AUA, NCCN, NICE). Bladder Cancer. 2016, 2:27-36. 10.3233\/BLC-150034","journal-title":"Bladder Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk M","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O, et al.. European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ). Eur Urol. 2022, 81:75-94. 10.1016\/j.eururo.2021.08.010","journal-title":"Eur Urol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2019.03.012","article-title":"Carcinoma in situ of the urinary bladder: a systematic review of current knowledge regarding detection, treatment, and outcomes","volume":"6","author":"Subiela JD","year":"2020","unstructured":"Subiela JD, Rodr\u00edguez Faba O, Guerrero Ramos F, Vila Reyes H, Pisano F, Breda A, Palou J. Carcinoma in situ of the urinary bladder: a systematic review of current knowledge regarding detection, treatment, and outcomes. Eur Urol Focus. 2020, 6:674-82. 10.1016\/j.euf.2019.03.012","journal-title":"Eur Urol Focus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/00005392-200102000-00005","article-title":"Human complement factor H related protein test for monitoring bladder cancer","volume":"165","author":"Raitanen MP","year":"2001","unstructured":"Raitanen MP, Marttila T, Nurmi M, Ala-Opas M, Nieminen P, Aine R, Tammela TL. Human complement factor H related protein test for monitoring bladder cancer. J Urol. 2001, 165:374-7. 10.1097\/00005392-200102000-00005","journal-title":"J Urol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800262","article-title":"ImmunoCyt\/uCyt+ improves the sensitivity of urine cytology in patients followed for urothelial carcinoma","volume":"18","author":"T\u00eatu B","year":"2005","unstructured":"T\u00eatu B, Tiguert R, Harel F, Fradet Y. ImmunoCyt\/uCyt+ improves the sensitivity of urine cytology in patients followed for urothelial carcinoma. Mod Pathol. 2005, 18:83-9. 10.1038\/modpathol.3800262","journal-title":"Mod Pathol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21843","article-title":"Improved risk stratification for patients with high-grade urothelial carcinoma following application of the Paris System for Reporting Urinary Cytology","volume":"125","author":"Cowan ML","year":"2017","unstructured":"Cowan ML, Rosenthal DL, VandenBussche CJ. Improved risk stratification for patients with high-grade urothelial carcinoma following application of the Paris System for Reporting Urinary Cytology. Cancer Cytopathol. 2017, 125:427-34. 10.1002\/cncy.21843","journal-title":"Cancer Cytopathol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21999","article-title":"One year of experience using the Paris System for Reporting Urinary Cytology","volume":"126","author":"Meilleroux J","year":"2018","unstructured":"Meilleroux J, Daniel G, Aziza J, et al.. One year of experience using the Paris System for Reporting Urinary Cytology. Cancer Cytopathol. 2018, 126:430-6. 10.1002\/cncy.21999","journal-title":"Cancer Cytopathol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1089-0","article-title":"Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer","volume":"15","author":"Todenh\u00f6fer T","year":"2015","unstructured":"Todenh\u00f6fer T, Hennenlotter J, Guttenberg P, et al.. Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer. BMC Cancer. 2015, 15:155. 10.1186\/s12885-015-1089-0","journal-title":"BMC Cancer"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2014.06.068","article-title":"Bladder biopsy of normal-appearing mucosa is not helpful in patients with unexplained positive cytology after nonmuscle invasive bladder cancer","volume":"193","author":"Musser JE","year":"2015","unstructured":"Musser JE, O'Shaughnessy MJ, Kim PH, Herr HW. Bladder biopsy of normal-appearing mucosa is not helpful in patients with unexplained positive cytology after nonmuscle invasive bladder cancer. J Urol. 2015, 193:48-52. 10.1016\/j.juro.2014.06.068","journal-title":"J Urol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/156184-limited-value-of-bladder-wash-cytology-during-follow-up-of-patients-with-non-muscle-invasive-bladder-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:59Z","timestamp":1707508919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/156184-limited-value-of-bladder-wash-cytology-during-follow-up-of-patients-with-non-muscle-invasive-bladder-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,12]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.40283","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,12]]}}}